Seppe Cambier

940 total citations · 1 hit paper
9 papers, 460 citations indexed

About

Seppe Cambier is a scholar working on Oncology, Immunology and Infectious Diseases. According to data from OpenAlex, Seppe Cambier has authored 9 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Seppe Cambier's work include Chemokine receptors and signaling (3 papers), Immune Response and Inflammation (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Seppe Cambier is often cited by papers focused on Chemokine receptors and signaling (3 papers), Immune Response and Inflammation (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Seppe Cambier collaborates with scholars based in Belgium, Brazil and United States. Seppe Cambier's co-authors include Paul Proost, Mieke Gouwy, Pedro Elias Marques, Sofie Vandendriessche, Mieke Metzemaekers, Sofie Struyf, Noëmie Pörtner, Marfa Blanter, Rafael Elias Marques and Els Wauters and has published in prestigious journals such as International Journal of Molecular Sciences, Cellular and Molecular Life Sciences and Frontiers in Immunology.

In The Last Decade

Seppe Cambier

9 papers receiving 457 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention

2023 260 citations Seppe Cambier, Mieke Gouwy et al. Cellular and Molecular Immunology profile →

Peers

Countries citing papers authored by Seppe Cambier

Since Specialization

Citations

This map shows the geographic impact of Seppe Cambier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seppe Cambier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seppe Cambier more than expected).

Fields of papers citing papers by Seppe Cambier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seppe Cambier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seppe Cambier. The network helps show where Seppe Cambier may publish in the future.

Co-authorship network of co-authors of Seppe Cambier

This figure shows the co-authorship network connecting the top 25 collaborators of Seppe Cambier. A scholar is included among the top collaborators of Seppe Cambier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seppe Cambier. Seppe Cambier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	The Immunopathology of Pulmonary Rejection after Murine Lung Transplantation 2024 ·Cells ·Janne Kaes, (unknown), (unknown), (unknown), (unknown), Seppe Cambier, Xin Jin, Jan Van Slambrouck, (unknown), (unknown), Greetje Vande Velde, Dirk Van Raemdonck, Ali Önder Yildirim, Philippe E. Van den Steen, Robin Vos, Laurens J. Ceulemans, Bart Vanaudenaerde	1
2	Heterogeneous neutrophils in lung transplantation and proteolytic CXCL8 activation in COVID-19, influenza and lung transplant patient lungs 2024 ·Cellular and Molecular Life Sciences ·Seppe Cambier, (unknown), (unknown), Mieke Metzemaekers, Noëmie Pörtner, Janne Kaes, (unknown), (unknown), (unknown), (unknown), Mieke Gouwy, Sofie Struyf, Rafael Elias Marques, Laurens J. Ceulemans, Joost Wauters, Bart Vanaudenaerde, Robin Vos, Paul Proost	2
3	Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients 2023 ·Cellular and Molecular Life Sciences ·Seppe Cambier, (unknown), Noëmie Pörtner, Mieke Metzemaekers, (unknown), Erik Martens, Janne Kaes, (unknown), Cato Jacobs, Pierre Van Mol, Els Wauters, Philippe Meersseman, Greet Hermans, Rafael Elias Marques, Bart Vanaudenaerde, Robin Vos, Joost Wauters, Mieke Gouwy, Paul Proost	6
4	The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention breakdown → 2023 ·Cellular and Molecular Immunology ·Seppe Cambier, Mieke Gouwy, Paul Proost	260
5	Nitration of chemokine CXCL8 acts as a natural mechanism to limit acute inflammation 2023 ·Cellular and Molecular Life Sciences ·(unknown), (unknown), Krishna Mohan Sepuru, Seppe Cambier, Thomas P Hellyer, Jonathan Scott, A. John Simpson, Paul Proost, John A. Kirby, Krishna Rajarathnam, Neil Sheerin, Simi Ali	5
6	Method Matters: Effect of Purification Technology on Neutrophil Phenotype and Function 2022 ·Frontiers in Immunology ·Marfa Blanter, Seppe Cambier, (unknown), (unknown), Noëmie Pörtner, (unknown), Mieke Metzemaekers, Pedro Elias Marques, Sofie Struyf, Paul Proost, Mieke Gouwy	39
7	Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza 2021 ·JCI Insight ·Seppe Cambier, Mieke Metzemaekers, (unknown), (unknown), Cato Jacobs, Lore Vanderbeke, Bert Malengier‐Devlies, Mieke Gouwy, Elisabeth Heylen, Philippe Meersseman, Greet Hermans, Els Wauters, Alexander Wilmer, Dominique Schols, Patrick Matthys, Ghislain Opdenakker, Rafael Elias Marques, Joost Wauters, Jennifer Vandooren, Paul Proost	39
8	Affinity and Specificity for Binding to Glycosaminoglycans Can Be Tuned by Adapting Peptide Length and Sequence 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Seppe Cambier, (unknown), Noëmie Pörtner, (unknown), Sofie Struyf, Tanja Gerlza, Andreas J. Kungl, Paul Proost	11
9	Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis 2021 ·Frontiers in Cell and Developmental Biology ·Sofie Vandendriessche, Seppe Cambier, Paul Proost, Pedro Elias Marques	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact